{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:04:12Z","timestamp":1788321852800,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/igc.0b013e3182a5055e","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T08:40:22Z","timestamp":1381740022000},"page":"1620-1628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Redefining Stage I Endometrial Cancer"],"prefix":"10.1016","volume":"23","author":[{"given":"Joyce N.","family":"Barlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Soslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin C.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn M.","family":"St. Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Mario M.","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Iasonos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martee L.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Matias-Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e3182a5055e_bb0005","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0010","first-page":"825","article-title":"Surgical staging in endometrial cancer: clinical-pathologic f indings of a prospective study","volume":"63","author":"Boronow","year":"1984","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0015","first-page":"2035","article-title":"Surgical pathologic spread patterns of endometrial cancer","volume":"60","author":"Creasman","year":"1987","journal-title":"A Gynecologic Oncology Group Study. Cancer."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0030","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/biomet\/92.4.965","article-title":"Concordance probability and discriminatory power in proportional hazards regression","volume":"92","author":"Gonen","year":"2005","journal-title":"Biometrika."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0040","first-page":"S3","article-title":"Why cancer staging? FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Benedet","year":"2006","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijgo.2007.11.004","article-title":"History of the FIGO cancer staging system","volume":"101","author":"Odicino","year":"2009","journal-title":"Int J Gynecol Obstet."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0050","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/IGC.0b013e31820cc305","article-title":"The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?","volume":"21","author":"Abu-Rustum","year":"2011","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0055","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0002-9378(85)90371-0","article-title":"Risk factors and recurrent patterns in stage I endometrial carcinoma","volume":"151","author":"DiSaia","year":"1984","journal-title":"Am J Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0065","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/his.12096","article-title":"ER\/PR\/TFF3\/IMP3 immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases","volume":"62","author":"Mhawech-Fauceglia","year":"2013","journal-title":"Histopathology."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2010.06.024","article-title":"Higher sensitivity to patupilone versus paclitaxel chemotherapy in primary uterine serous papillary carcinoma cell lines with high versus low HER-2\/neu expression in vitro","volume":"119","author":"Paik","year":"2010","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2005.06.012","article-title":"Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy","volume":"98","author":"Kelly","year":"2005","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2012.10.027","article-title":"Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional study","volume":"128","author":"Winer","year":"2013","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0085","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/IGC.0b013e31823de6dd","article-title":"Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system","volume":"22","author":"Seward","year":"2012","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ygyno.2012.10.025","article-title":"Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas","volume":"128","author":"Ayeni","year":"2013","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0095","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/PAS.0b013e31802ee494","article-title":"Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences","volume":"31","author":"Soslow","year":"2007","journal-title":"Am J Surg Pathol."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(02)02913-9","article-title":"Is there a difference in outcome between stage I-II endometrial cancer of papillary serous\/clear cell and endometrioid FIGO Grade 3 cancer?","volume":"54","author":"Alektiar","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/WHE.10.85","article-title":"The current status of lymphadenectomy in the management of endometrial cancer","volume":"7","author":"Creasman","year":"2011","journal-title":"Womens Health (Lond Engl)."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0110","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"ASTEC Study Group","year":"2009","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0120","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2012.02.021","article-title":"The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes","volume":"125","author":"Barlin","year":"2012","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ygyno.2011.04.030","article-title":"Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes","volume":"122","author":"Khoury-Collado","year":"2011","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0130","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/IGC.0b013e318269e29d","article-title":"Determinants of lymph node count in endometrial cancer surgical staging","volume":"22","author":"Cormier","year":"2012","journal-title":"IntJ Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e3182a5055e_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.01.010","article-title":"Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?","volume":"198","author":"Abu-Rustum","year":"2008","journal-title":"Am J Obstet Gynecol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2408558X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2408558X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e3182a5055e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:09:33Z","timestamp":1753232973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2408558X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1048891X2408558X"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e3182a5055e","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining Stage I Endometrial Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e3182a5055e","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}